CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy
Blood Dworzak et al.
112: 3982
Supplemental materials for: Dworzak et al
The Associazione Italiana Ematologia Oncologia Pediatrica–Berlin-Frankfurt-Münster-Acute Lymphoblastic Leukemia–Flow Cytometry–Minimal Residual Disease Study Group
Michael N. Dworzak1
Angela Schumich1
Zvenyslava Husak1
Dieter Printz1
Giuseppe Basso2
Marinella Veltroni2
Alessandra Benetello2
Giuseppe Gaipa3
Andrea Biondi3
Oscar Maglia3
Simona Sala3
Richard Ratei4
Leonid Karawajew4
Wolf-Dieter Ludwig4
Marianne Dunken4
1Children’s Cancer Research Institute, Vienna, Austria
2Laboratory of Pediatric Onco-Hematology, Department of Pediatrics, University Hospital of Padova, Padova, Italy
3Tettamanti Research Center, Department of Pediatrics, University of Milano-Bicocca, Ospedale San Gerardo, Monza, Italy
4Dept. of Hematology, Oncology and Tumor Immunology, Robert-Roessle-Clinic at the HELIOS Klinikum Berlin, Charité Medical School, Berlin, Germany